Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection
- PMID: 19954299
- DOI: 10.1089/aid.2008.0303
Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection
Abstract
It has recently been demonstrated that toll-like receptors (TLRs) can recognize structural conserved motifs carried by circulating microbial products and lead to systemic immune responses in individuals infected with HIV-1. TLRs have been detected in CD8(+) T cells at either a protein or RNA level. The role of TLRs on CD8(+) T cells involved in the host's immune responses during HIV-1 infection has not been well characterized. In this study, we analyzed expression of TLR4, TLR5, TLR7, and TLR8 in CD8(+) T cells in HIV-1 infection. All these four TLRs could be detected in CD8(+) T cells, but only TLR7 in CD8(+) T cells from HIV-1-infected individuals showed a higher expression level compared with that from healthy individuals (p < 0.05). The function of TLR7 in CD8(+) T cells was then investigated. We found that TLR7 ligand responsiveness significantly increased the expression of immune activation markers on purified CD8(+) T cells in HIV-1-infected individuals compared with healthy controls. And the levels of these markers were equivalent to those achieved by CD8(+) T cells from peripheral blood mononuclear cells (PBMCs). However, we also observed that TLR7 ligand stimulated significant IFN-gamma production by CD8(+) T cells in an accessory cell-dependent manner. Therefore, although CD8(+) T cells can be directly activated by TLR7, accessory cells must play an essential role in the activation of effective functions such as IFN-gamma production. These findings suggest that the abnormal expression of TLR7 in CD8(+) T cells from HIV-1-infected individuals may contribute to the abnormal immune activation in HIV-1 infection and play an important role in HIV-1 pathogenesis.
Similar articles
-
HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.Biomed Environ Sci. 2010 Oct;23(5):391-401. doi: 10.1016/S0895-3988(10)60081-5. Biomed Environ Sci. 2010. PMID: 21112488
-
TLR7 Modulated T Cell Response in the Mesenteric Lymph Node of Schistosoma japonicum-Infected C57BL/6 Mice.J Immunol Res. 2019 Dec 22;2019:2691808. doi: 10.1155/2019/2691808. eCollection 2019. J Immunol Res. 2019. PMID: 31930147 Free PMC article.
-
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.J Virol. 2017 Mar 29;91(8):e02166-16. doi: 10.1128/JVI.02166-16. Print 2017 Apr 15. J Virol. 2017. PMID: 28179531 Free PMC article.
-
Modulation of the strength and character of HIV-specific CD8+ T cell responses with heteroclitic peptides.AIDS Res Ther. 2017 Sep 12;14(1):41. doi: 10.1186/s12981-017-0170-y. AIDS Res Ther. 2017. PMID: 28893274 Free PMC article. Review.
-
Toll-like receptor-2/7-mediated T cell activation: An innate potential to augment CD8+ T cell cytokine production.Scand J Immunol. 2021 May;93(5):e13019. doi: 10.1111/sji.13019. Epub 2021 Jan 19. Scand J Immunol. 2021. PMID: 33377182 Review.
Cited by
-
Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis.Front Immunol. 2019 Sep 12;10:2191. doi: 10.3389/fimmu.2019.02191. eCollection 2019. Front Immunol. 2019. PMID: 31572396 Free PMC article.
-
CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy.Front Immunol. 2019 Aug 9;10:1896. doi: 10.3389/fimmu.2019.01896. eCollection 2019. Front Immunol. 2019. PMID: 31447862 Free PMC article. Review.
-
Direct Toll-Like Receptor 8 signaling increases the functional avidity of human CD8+ T lymphocytes generated for adoptive T cell therapy strategies.Immun Inflamm Dis. 2015 Mar;3(1):1-13. doi: 10.1002/iid3.43. Epub 2015 Feb 19. Immun Inflamm Dis. 2015. PMID: 25866635 Free PMC article.
-
TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells.Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01369-16. doi: 10.1128/AAC.01369-16. Print 2017 Jan. Antimicrob Agents Chemother. 2016. PMID: 27799218 Free PMC article.
-
Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.AIDS Res Hum Retroviruses. 2013 Jun;29(6):907-18. doi: 10.1089/aid.2012.0313. Epub 2013 Feb 5. AIDS Res Hum Retroviruses. 2013. PMID: 23316755 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous